CAPPUZZELLO, ELISA

CAPPUZZELLO, ELISA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Risultati 1 - 11 di 11 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autore(i) Rivista Serie Titolo libro
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies 2016 CAPPUZZELLO, ELISATOSI, ANNAZANOVELLO, PAOLASOMMAGGIO, ROBERTAROSATO, ANTONIO ONCOIMMUNOLOGY - -
A DONOR-DEPENDENT SUBSET OF CYTOKINE-INDUCED KILLER (CIK) CELLS EXPRESS CD16 AND CAN BE RETARGETED TO EXERT A POTENT ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC) 2016 Cappuzzello, Elisa - - -
Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy 2017 Cappuzzello, Elisa + TRANSFUSION MEDICINE AND HEMOTHERAPY - -
Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells 2017 CAPPUZZELLO, ELISASOMMAGGIO, ROBERTAZANOVELLO, PAOLAROSATO, ANTONIO CYTOKINE & GROWTH FACTOR REVIEWS - -
Glucocorticoid receptor signalling activates YAP in breast cancer 2017 CAPPUZZELLO, ELISAROSATO, ANTONIO + NATURE COMMUNICATIONS - -
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1 2017 TOSI, ANNADALLA SANTA, SILVIACAPPUZZELLO, ELISAZANOVELLO, PAOLASOMMAGGIO, ROBERTAROSATO, ANTONIO + ONCOIMMUNOLOGY - -
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action 2017 CAPPUZZELLO, ELISAROSATO, ANTONIO + NATURE COMMUNICATIONS - -
Fc glyco- and fc protein-engineering: Design of antibody variants with improved ADCC and CDC Activity 2018 Elisa CappuzzelloPEIPP, MATTHIAS + - - Methods in Molecular Biology
Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells 2020 Sommaggio R.Cappuzzello E.Dalla Pieta A.Tosi A.Palmerini P.Carpanese D.Rosato A. + ONCOIMMUNOLOGY - -
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks 2020 Palmerini P.Dalla Pieta A.Sommaggio R.Ventura A.Cappuzzello E.Rosato A. + CYTOTHERAPY - -
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells 2021 Cappuzzello E.Palmerini P.Ventura A.Visentin A.Trentin L.Sommaggio R.Rosato A. + JOURNAL FOR IMMUNOTHERAPY OF CANCER - -